They will need to run phase 2 in migraine etc first. They probably can go into phase 3 for spasticity since they have some data and closely related to CD as well (and may get some off label use in these closely related conditions) I would be surprised if RVNC is spearheading therapeutic indications - it will be a partner or whoever gobbles them up